CLINICAL_TRIALS
trial_result
· 2019-01-15
Clinical Trial Update: Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly [Phase 3]
Summary
Phase 3 trial update reporting efficacy and tolerability of lanreotide (Autogel 120 mg) in acromegaly.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Acromegaly | Phase 3 | Status: COMPLETED